This inventor holds 3 USPTO granted patents, plus 2 CIPO patents. Top assignees: Ampsource Biopharma Shanghai Inc., Livzon Mabpharm Inc., Other. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 4 
1 out of 834,513 Years Active: 2014-2023
Title: Cecily Rou-Yun Sun: Innovator in Antibody Development
Introduction
Cecily Rou-Yun Sun is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents, her work focuses on innovative solutions for pain management and immunotherapy.
Latest Patents
One of her latest patents is titled "Anti-human NGF antibodies and methods using same." This invention provides an antibody and/or an antigen binding fragment that binds to nerve growth factor (NGF). The amino acid sequences of the heavy chain and light chain variable regions of the antibody are included in this patent. The NGF antibody and/or its antigen binding fragment has a high affinity for NGF and can effectively block the binding between the NGF receptor and NGF. This innovation can inhibit the binding activity of NGF and its receptor in vitro, making it suitable for treating pain diseases related to the heightened expression of NGF.
Another significant patent is "Humanized anti-TNFα antibodies." This invention presents a humanized anti-TNF monoclonal antibody that significantly reduces the immunogenicity of murine antibodies while retaining the ability to recognize antigens. Compared to traditional mouse chimeric antibodies, this humanized version improves safety in clinical applications.
Career Highlights
Cecily has worked with various companies, including Ampsource Biopharma Shanghai Inc. Her expertise in antibody development has positioned her as a key player in the biotechnology sector.
Collaborations
Cecily has collaborated with notable individuals in her field, including Bill Nai-Chau Sun and Lee-Hwei King Sun. These collaborations have further enhanced her research and development efforts.
Conclusion
Cecily Rou-Yun Sun is a trailblazer in the field of antibody innovation, with a focus on therapeutic applications that address critical health issues. Her contributions continue to impact the biotechnology landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile